If you have been diagnosed with hypertension, you are likely already aware of how closely your weight and blood pressure are linked
Randomised controlled trials involving GLP-1RA have not detected suicidality signals, but these studies were underpowered to detect rare events such as SIS, and they selectively exclude individuals with psychiatric comorbidity [23,24,25,26], which are prevalent in daily practice
No media logos, no third-party award claims, and no testing or partnership claims that need backing up
The medication is manufactured only by Novo Nordisk
Regulatory agencies have examined the potential for GLP-1 agonists to cause adverse psychiatric effects, including suicidal ideation
Disclaimer: BPC-157 is not approved by the FDA for any medical application